Hints and tips:
Related Special Reports
Related Topics
...Corporate earnings reports out today include Toyota Motor, NTT Data, Sumitomo Electric Industries, Mitsubishi Motors, Kepco, Singapore Airlines and Cipla....
...Yusuf Hamied, chairman of Cipla, the Indian generics company, says his efforts to provide the drug praziquantel, used to treat schistosomiasis (or bilharzia), at a low cost have been undercut by large donations...
...At Cipla we have a happy blend of social obligations and business.”...
...Murali Neelakantan, former general counsel for Cipla, India’s fourth-largest drugmaker by sales, agrees that the Indian laboratory practices raising concerns among regulators have deep roots, but that it...
...Yusuf Hamied, for example, is often described as India’s “generics king” for his work developing affordable medicines during his lengthy spell as chairman of low-cost pharmaceutical maker Cipla....
...However, he said Cipla is asking distributors to ensure sofosbuvir purchasers have valid prescriptions from Indian doctors, and it plans to regularly monitor the general flow of the drug....
...Subhanu Saxena, chief executive of Cipla, said the deal showed that drugmakers had learned the lessons of past controversy over pricing of HIV drugs....
...meanwhile, big pharma has been waging a running battle over intellectual property, as regulators have opened some patent-protected medicines to low-cost generic production by local manufacturers such as Cipla...
...For generic manufacturers such as Teva, Mylan and Actavis, the pressure has come from the rise of lower-cost Indian rivals such as Sun Pharma and Cipla....
...Cipla would provide the formulation while Meda will be responsible for development and sales, the Swedish company said....
...“Cipla has very little stake in oncology, only $3m of sales comes from this class of drugs, so it’s not a very big hit on their numbers,” he said. “So they will only gain....
...India’s market for Nexavar and its generic equivalents is estimated at only about $6m, which is shared between Bayer, Natco and Cipla....
...There is intensifying pressure on medicine prices in India, with other generic companies led by Cipla seeking to overturn patents on a range of drugs, in a challenge that large pharmaceutical groups argue...
...Related reading: Cipla’s enlightened self-interest, beyondbrics India approves generic cancer drug, FT Ranbaxy’s high blood pressure day, beyondbrics...
...WHO good manufacturing practices certified pharmaceutical plant outside of South Africa, manufacturing generic anti-retroviral and anti-malarial drugs in partnership with local Ugandan entrepreneurs and Cipla...
...Yusuf Hamied, head of Cipla, one of the largest Indian generic drug makers, said: “If this license is fair, reasonable and equitable, we will accept it.”...
...unusual display of solidarity with one of his Indian rivals, Dr Anji Reddy, founder of the company, opened the new headquarters on Monday jointly with Yusuf Hamied, head of the Indian generics business Cipla...
...That helped establish Desano as a producer of the finished drugs for the domestic market, while the know-how provided by Cipla has helped it win supply contracts with other companies and certification of...
...since 2004, after sustained international pressure and an inflow of foreign financing, has marked a sharp turn for a government that long resisted pleas to provide free drugs to Aids patients even while Cipla...
...“It’s about monopoly and delay,” says Yusuf Hamied, head of Cipla, who initially thought that once GSK had lost the patents in its home market in 2004 it would desist....
...This has restricted Cipla’s ability to sell its version of the drug....
...Yusuf Hamied, head of Cipla, the Indian generics company that is one of the largest providers of stavudine and other HIV treatments, dismissed the financial impact, pointing out that he could also sell Gilead...
...Yusuf Hamied, head of Cipla, said: “I am absolutely delighted. This is one of the world’s largest anti-Aids drugs and now I am free to promote it.”...
...Authorities have held up shipments of Indian generic drugs, including consignments from Cipla, the Mumbai-based pharmaceutical company, on the grounds that they violated patents....
...Meanwhile Cipla, an Indian generic company, indicated that it was ready to produce a cheaper equivalent version rapidly and in large quantities, but was awaiting authorisation from the World Health Organisation...
International Edition